Athersys, Inc. Receives Orphan Drug Designation for MultiStem in Hurler's Syndrome

Full story: BioSpace
Athersys, Inc. announced today that MultiStemA , Athersys' proprietary cell therapy, has been granted orphan drug designation by the U.S. Food and Drug Administration for the treatment of Hurler's Syndrome, also known as mucopolysaccharidosis type I or MPS-I. Hurler's Syndrome is a lysosomal storage disorder that affects approximately 1 of every ... (more) Full Story
athxer

Singapore, Singapore

#1 Jul 11, 2012
any idea when a partnership for this is happening??? Don;t wish to see another dilution exercise.
athxer

Singapore, Singapore

#2 Jul 17, 2012
I'm starting to loose patience at Athersys. Whenever there's slightest bit of positive news, this damn stock will go down and remain down.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
Viagra may work for women, too (Jul '08) 18 hr Teras 25
Fight over $1,100 hepatitis C pills awaits next... Mon reneir880 1
Dr. Reddy's Launches Authorized Generic Version... (Nov '08) Dec 22 Lil 57
Syphilis on the Rise Among Gay, Bisexual Men: CDC Dec 17 Antoine 4
Second Doctor Implicated In La Jolla Surgeon's ... (Apr '08) Dec 17 StayAway 41
Merck's MSD Pharma to create 800 jobs in India (Nov '08) Dec 15 BASAVARAJ G 221
Anti-smoking drugs to carry mental-health warnings (Jul '09) Dec 14 Smokin IS crazy 10
More from around the web